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j Abstract Objective EEG investigation in patients
with an at risk mental state (ARMS) for psychosis and
patients with a first episode of psychosis (FE) in
comparison to healthy controls (HC) in a clinical
follow up study of Early Detection of Psychosis.
Method Seventy-three patients (42 ARMS, 31 FE) and
35 HC were investigated. ARMS patients were fol-
lowed up in order to monitor transition to psychosis.
Psychopathology was assessed with respect to positive
and negative symptoms. At study baseline EEG was
recorded using the 10/20 system. Two blinded neu-
rologists analyzed the EEGs visually for presence of
generalized or focal slowing and epileptiform dis-
charges. EEG data were controlled for medication
and substance abuse. For statistical analyses we used
v2-tests, logistic regression, ANOVA, and receiver
operating characteristics. Results Patients showed
significantly more pathological EEG abnormalities
than HC (P < 0.05), located more frequently in tem-
poral or fronto-temporal regions (P < 0.01) of the
brain, with twice as many pathologies in ARMS than
in FE patients. The specificity of the prediction of
psychosis could be increased from 59 to 73% by
considering EEG pathology in addition to psychopa-
thology alone. In contrast, sensitivity of prediction
remained unchanged. Conclusions These results show
that EEG investigation in patients at risk for psychosis
can add to the identification of those patients who will
not develop psychosis later on.
j Key words psychosis Æ schizophrenia Æ EEG Æ
marker Æ detection Æ prediction Æ neurophysiology
Introduction
The main role of EEG in the clinical diagnosis of
patients with a schizophrenia-like syndrome is to
detect organic brain diseases such as epilepsy or
limbic encephalitis. While the schizophrenia-like
psychosis of epilepsy [11, 15, 26] constitutes a special
diagnostic difficulty, chronic and first episode
schizophrenia itself may be associated with EEG
pathologies in 23–44% [6, 24, 28], even if never
treated with antipsychotic drugs [27]. However, no
single pattern of EEG abnormality in chronic or first
episode schizophrenia has been identified. Increased
prevalence of EEG pathologies in patients with a first
episode of psychosis (FE) [4, 24] remains controver-
sial [18]. If present, these pathologies seem to be
associated with a worse prognosis [12–14]. While
relatives of schizophrenic patients showed an increase
of slow activity [1, 4], no data is available on EEG
recordings in individuals being clinically in a pro-
dromal phase of the disease. Moreover, while some
studies with FE patients were conducted, to our
knowledge no longitudinal studies have been per-
formed in individuals at risk for psychosis with or
without later transition to psychosis.
The present investigation forms a part of a pro-
spective, multilevel study to identify characteristics
that allow the differentiation of patients with a true
prodromal phase of schizophrenia from those with a
similar clinical syndrome who will not develop psy-
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chosis later on [17]. The purpose of the present study
was to evaluate the contribution of EEG to the
assessment of the risk for transition to psychosis in at
risk mental state (ARMS).
Methods
j Patients
A specialized Early Recognition Clinic for Psychosis was estab-
lished at the Psychiatric Outpatient Department of the University
Hospital Basel, Switzerland. The referrals with suspected psychosis
came mainly from general practitioners, psychiatrists in private
practices, and from our Psychiatric Outpatient Department. The
screening procedure using the Basel Screening Instrument for
Psychosis [16] was based on the most important risk factors for and
potential indicators of beginning schizophrenia (e.g. genetic risk,
psychopathological and psychosocial changes). The inclusion cri-
teria and the cut-off for transition to psychosis was defined using
the Brief Psychiatric Rating Scale (BPRS) according to Yung et al.
[30]. Subjects were included as at risk if they fulfilled the following
criteria.
Criteria 1.1—‘‘Attenuated psychotic symptoms’’ (scores of 2 or 3
on the hallucination item, 3 or 4 on the ‘‘unusual thought content’’
or ‘‘suspiciousness’’ items of the BPRS for at least several times a
week and persisting for more than 1 week) or
Criteria 1.2—‘‘Brief Limited Intermittent Psychotic Symptoms’’
(BLIPS—scores of 4 or above on the ‘‘hallucinations’’ item, or 5 or
above on the ‘‘unusual thought content’’, ‘‘suspiciousness’’ or
‘‘conceptual disorganization’’ items of the BPRS, with each symp-
tom lasting less than 1 week before resolving spontaneously) or
Criteria 2—genetic risk and at least two further risk factors
according to the screening instrument, such as social decline or
prodromal symptoms or
Criteria 3—a minimal amount and combination of unspecific risk
factors according to the BSIP [16].
Inclusion criteria 1 and 2 correspond to the ARMS subjects
(high risk) of Yung et al. [31], and criterion 3 additionally permits
the inclusion of patients at presumably lower risk, who display only
certain prodromal symptoms and social decline. All analyses were
carried out on data concerning the total sample of ARMS high risk
and ARMS low risk individuals.
Individuals in an at-risk mental state for psychosis (ARMS)
were compared to patients with a FE and to healthy controls (HC).
HC were recruited from trade schools, hospital staff and through
advertisements. They had no history of psychiatric or neurological
disease, no past or present substance abuse or head trauma. A
formal neurological examination of all patients and HC showed
normal findings. Patients with previously diagnosed schizophrenia,
substance-induced psychosis, age below 18 years, inadequate
knowledge of the German language, and intelligence below an IQ of
70 were excluded.
During the first year of follow-up, ARMS individuals were as-
sessed monthly, during the second and third year every third
month, and afterwards once a year. Transition to psychosis was
monitored using the transition criteria [30].
During the first 3 years of inclusion we screened 206 individuals
for beginning psychosis, 98 of whom were classified as being at risk
for psychosis and 76 of them as psychotic, 32 had other psychiatric
diseases (e.g. anxiety disorder). Of the remaining 174 patients, 58
ARMS individuals and 36 patients with a FE consented to partici-
pate in the study. Forty-two ARMS individuals, 31 first episode
patients and 35 HC could be investigated with EEG. During a fol-
low-up period of 72 months 12 of the 42 ARMS individuals made
the transition to psychosis and eight were lost to follow-up. If
during follow-up an ARMS individual was known to receive neu-
roleptic medication that person was considered as dropping out
from the study. Data from the ARMS-patients were analyzed with
regard to transition and no transition to psychosis. For sample
description see Table 1.
At baseline, statistical differences were found between the
groups’ age, educational level, neuroleptics and cannabis intake.
However, these differences were statistically balanced across sub-
groups with the consequence that post hoc-tests did not show any
statistically significant differences. Differences in EEG were tested
by v2 test and ANOVA with SPSS for Windows, Version 14.
Level of significance was set at P < 0.05. The study was ap-
proved by the local ethics committee. After complete description of
the study to the subjects, written informed consent was obtained
from all participants.
Study design
j EEG recording and analyses
Routine EEG recordings were performed in a quiet room with the
patients either sitting or in supine position with closed eyes; the
recordings lasted for about 20 min and included several episodes of
open and closed eyes, as well as hyperventilation and photic
stimulation.
The EEGs were digitally recorded using the international 10/20
system. Impedances were kept below 5 kX. Amplifiers were cali-
brated using a 50 lV square pulse. Sampling frequency was
250 Hz with 0.5–70 Hz filters. All channels were recorded against
the mastoids. Each EEG recording was independently analyzed by
two neurologists who were blinded to the patients’ clinical data
and diagnostic group category. Generalized or focal slowing,
spikes and sharp waves, as well as pathological rhythmic patterns
were assessed, and special care was taken to identify normal
variants. Pathological rhythmic patterns were defined as repetitive
discharges not corresponding to one of the known benign EEG
variants (e.g. signs of drowsiness such as rhythmic mid-temporal
discharges (RMTD), subclinical rhythmic electrographic dis-
charges in adults (SREDA) and wicket spikes, or midline theta
rhythms, etc.). Multiple responses were possible. Because of an
inter-rater reliability close to 1.0 there was no need to calculate
the Kappa-value.
The severity of EEG pathology was scored similar to Centorrino
et al. [3] as follows: 0 = no abnormality, 1 = mild abnormality
(theta and delta slowing), 2 = moderate abnormality (sharp waves,
pathological rhythmic pattern), 3 = severe abnormality (combina-
Table 1 Demographic characteristics, neuroleptics, and cannabis abuse of healthy controls, ARMS individuals and patients with a first episode of psychosis
HC (N = 35) ARMS (N = 42) FE (N = 31)
Age (years ± SD) 23.9 ± 6.2 27.9 ± 8.7 31.7 ± 7.3 Fdf=2,105 = 10.0; P < 0.001
Gender (f/m) 13/22 17/25 9/22 vdf
2
=2 = 1.04; P = 0.596
Neuroleptics 0 0 6 vdf
2
=2 = 20.6; P £ 0.001
THC use 0 13 10 vdf
2
=2 = 17.7; P < 0.001
Education (years ± SD) 11.2 ± 1.7 10.3 ± 2.4 10.0 ± 2.7 Fdf=2,105 = 2.9; P = 0.059
HC healthy controls, ARMS individuals in an ‘at risk mental state’ for psychosis, FE first episode patients
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tion of 1 and 2). In order to clarify the existence of substantial
associations between EEG pathology and psychopathology Scale of
the Assessment of Negative Symptoms (SANS) mean summary
score [2] and BPRS global score [29] were computed as function of
the degree of EEG pathology.
j Data analysis
First, any potential statistical interaction was tested for significance
with v2 and ANOVA. Then, a binary logistic regression model was
conducted and probabilities for developing psychosis were calcu-
lated in order to specify the contribution of EEG to the prediction
of psychosis. Finally, based on these probabilities, receiver oper-
ating characteristics (ROC) were determined and cut-off values
were derived in order to classify the ARMS individuals corre-
sponding to those who actually transited to psychosis and those
who did not.
Results
j Nature and localization of EEG pathology
Patients showed significantly more EEG abnormalities
(slow waves, pathological rhythmic patterns) com-
pared to HC (P < 0.05). The highest proportion of
pathological findings was observed in ARMS indi-
viduals (Table 2).
j Epileptiform activity and pathological slowing
Four parameters were analyzed: (a) sharp waves, (b)
spikes, (c) pathologic rhythmic patterns, (d) d- and h-
activity. Twenty-four patients of the first episode
group, 27 of the ARMS individuals, and 31 of HC
showed no pathology at all. Moreover, no spikes were
found in the whole sample. If more than one patho-
logical sign was detected, patterns of combined EEG
abnormalities were analyzed (see Fig. 1). In the ARMS
group, the most prominent pathological finding was
focal slowing, but no single pathological sign showed
a significantly different prevalence between patients
and HC (P = 0.80).
Pathological EEG findings were localized predom-
inantly in the temporal or fronto-temporal region.
Thirteen out of 42 ARMS individuals showed tem-
poral or fronto-temporal localization, only one pa-
tient had an occipital pathology. No pathology could
be detected in the parietal region of the brain. Three
patients (two-first episode patients, one ARMS indi-
vidual) showed generalized epileptiform activity
which was ignored in the analysis of localized brain
dysfunction. In total, 17 pathologies were unilateral,
seven pathologies were bilateral, two patients showed
both bi- and unilateral pathologies at different loca-
tions. There was no statistically significant difference
between the groups. The localization of pathological
findings in the fronto-temporal or temporal region
Table 2 Pathological EEGs (slow waves, pathological rhythmic patterns) of all
patients versus healthy controls (vdf
2
=2 = 6.2; P < 0.05)
HC (N = 35) ARMS (N = 42) FE (N = 31)
No pathology 31 27 24
Pathology 4 15 7
Pathological
rhythmic
patterns
Sharp
waves
Pathological
slow wave
activity
Pathological
slow wave
activity
Pathological
slow wave
activity
Pathological
slow wave
activity
Sharp
waves
Yes
Yes
No
No
Yes
0 0 0 0 0 0 4 31
0 0 1 1 2 1 10 27
1 0 0 1 1 0 4 24
HC (N = 35)
ARMS (N = 42)
FE (N = 31)
No Yes No Yes No Yes No
Yes No
Fig. 1 Pathological slowing and
epileptiform activity
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compared to other localizations was one of the most
stable findings of our study (P < 0.01).
j EEG pathology and psychopathology in ARMS
patients and FE
Psychopathology as assessed by BPRS (global score)
and SANS (summary score) was neither in ARMS nor
in FE associated with severity of EEG pathology.
j EEG pathology and psychopathology in ARMS
individuals with and without transition to
psychosis during a 7-year follow-up period
During the maximum follow up of 7 years 12 ARMS
individuals with an initial EEG recording transited to
frank psychosis (ARMS-T), further eight individuals
refused participation during follow-up and were
therefore lost for prospective analysis. Twenty-two
individuals did not make the transition to psychosis
during follow-up (ARMS-nT).
Seven (58%) out of 12 ARMS-T showed EEG pathol-
ogies (N = 5 slow waves, and N = 2 slow waves and
sharp waves), whereas only six (27%) out of 22 ARMS-
nT did (N = 4 slow waves, N = 1 sharp waves, and N = 1
slow waves and sharp waves). Differences between
groups were not statistically significant, probably due to
the relatively small sample size. There was no relation-
ship between SANS summary score, EEG pathology and
group assignment to ARMS-T and ARMS-nT.
However, psychopathology measured by the BPRS
global score at inclusion showed a significant inter-
action (F3,29 = 3.27; P = 0.035) of group assignment
with presence or absence of pathological EEG (Fig. 2).
ARMS-T individuals with EEG pathology had lower
BPRS global scores compared to those without.
j Prediction of psychosis
In order to evaluate the predictive value of the EEG
findings two logistic regression procedures were
performed. In both cases the dependant variable was
the binary coded group membership (ARMS-T vs.
ARMS-nT). While the first model addressed only
psychopathology measured by BPRS, a second model
considered both the psychopathology and the EEG
pathology. In both models psychopathology was
positively related to the transition to psychosis.
Severity of EEG pathology as additionally entered in
the second model likewise showed a positive rela-
tionship to the transition to psychosis.
Prediction of psychosis with psychopathology alone
The logistic regression procedure showed a significant
model predicting group assignment by psychopa-
thology measured by BPRS (vdf
2
=1 = 3.9; P = 0.049).
The odds-ratio for suffering from transition to psy-
chosis was estimated to increase by an amount of 1.08
(Walddf=1 = 3.56, P = 0.059) with BPRS score at
baseline increasing by one unit.
Moreover, based on the predicted probabilities as
yielded by the logistic regression procedure, a cut-off
value was derived by means of the ROC curve in
selecting a particular probability-value (P = 0.276)
according to a maximized sensitivity as well as spec-
ificity. The cut-off value was equivalent to a BPRS
score of 39. This procedure resulted in a sensitivity of
82% of correctly classified ARMS-T experiencing a
transition to psychosis and a specificity of 59% of
correctly classified ARMS-nT without transition to
psychosis (see Table 3).
Prediction of psychosis by combining psychopathology
and pathological EEG severity
In comparing alternative models the best choice was
one that specified psychopathology as well as patho-
logical EEG severity modeled as the main effect. The
pathologyno pathology
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Fig. 2 Mean BPRS Global Score as function of the transition to psychosis and
EEG pathology. Significant interaction of group assignment (ARMS-T vs. ARMS-
nT) with pathological EEG (F3,29 = 3.27; P = 0.035)
Table 3 Contingency table observed versus predicted ARMS (transited = T
and non-transited = nT) based on a binary logistic regression using only BPRS
global score as predictor
Observed
ARMS-nT ARMS-T
Predicted
ARMS-nT 13 2
ARMS-T 9 9
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model was highly significant (vdf
2
=2 = 10.5; P = 0.005)
and estimated the contribution of psychopathology to
the prediction of psychosis by an odds-ratio of 1.15
(Walddf=1 = 5.69, P = 0.017) whenever BPRS in-
creased by one unit. Most importantly, the odds-ratio
of suffering from transition to psychosis increased by
a value of 5.89 (Walddf=1 = 5.07, P = 0.024) if the
severity of EEG pathology was considered.
By applying the same strategy as above, a cut-off
value was determined using the ROC curve. Again,
this resulted in a sensitivity of 82%, but specificity
increased to a value of 73% (Table 4). Specificity and
sensitivity were associated with a cut-off value of
P = 0.340 (predicted probability).
This means that the detection of false positives
ARMS who will not make the transition to psychosis
could be improved by considering their EEG record-
ings which are free of pathologies (Fig. 3).
Discussion
Pathological signs are significantly more prevalent in
EEGs of FE and of ARMS than in those of HC, and
were predominantly localized in temporal or fronto-
temporal regions of the brain. However, there is no
association between the severity of both the psycho-
pathology and the EEG pathology. This is true with
regard to FE compared to ARMS on the one hand an
ARMS-T compared to ARMS-nT on the other hand.
ARMS-T showed a higher proportion of EEG pathol-
ogies than ARMS-nT even though this could not be
significantly testes against chance. When prediction of
psychosis is considered, the additional contribution
of EEG assessment increases the specificity of the
prediction of psychosis but leaves sensitivity un-
changed.
In general, patients (ARMS, FE) showed a higher
proportion of pathological abnormalities in the EEG
than HC. This indicates a higher vulnerability of
brain abnormalities in FE and even in its prodromal
state.
EEG pathologies were mostly located in the tem-
poral or fronto-temporal region. This result is in
accordance with earlier studies [5, 6, 15, 21, 22, 25].
While in some of them, left-sided pathology was the
most frequent finding, others found bilateral altera-
tions [9, 10, 20, 23]. Unilateral pathologies predomi-
nated in our patients, but left-sided locations did not
outweigh right-sided ones. As the present study is
based on visual analysis of EEG, the absence of find-
ings like diminished alpha activity or increased beta
activity as reported from quantitative EEG studies [4,
7, 8, 19] is limited to effects large enough to signifi-
cantly influence the visual analysis of clinical EEG,
which is aimed at the discovery of clear-cut pathology
in the individual rather than group effects.
Out of 35 HC in our study, four individuals showed
pathological slow wave activity, but none of them had
sharp waves, spikes or pathological rhythmic pat-
terns. The high percentage of slow wave pathologies
in the control group could have occurred by chance
due to a relatively small sample size.
While in the present study, ARMS individuals were
defined by clinical signs and symptoms, others who
examined patients with a purely genetic risk also
found a correlation between the mental state and the
severity of EEG pathologies [1].
The prediction of transition to psychosis based on
psychopathology alone is corresponding to a BPRS
global score of 39 and above. This means that any
patient presenting with a value of 39 or more is
classified as ARMS-T. Any patient who scores below
this value is viewed as not being at risk for transition
to psychosis.
Although more ARMS who later made the transi-
tion to psychosis had shown EEG pathologies than
ARMS without later transition this difference was not
significant. Also, the sensitivity of prediction does not
change when EEG pathology additionally to psycho-
pathology is considered. The value of 82% sensitivity
remains unaffected, regardless of the psychopathol-
ogy alone or in combination with EEG. In contrast,
Table 4 Contingency table observed versus predicted ARMS (transited = T
and non-transited = nT) based on a binary logistic regression using BPRS
global score as well as EEG pathology as predictor
Observed
ARMS-nT ARMS-T
Predicted
ARMS-nT 16 2
ARMS-T 6 9
1
0.8
0.6
0.4
0.2
0.2 0.4
1 - Specificity
line of no Information BPRS+EEG BPRS
Se
ns
iti
vi
ty
0.6 0.8 1
0
0
Fig. 3 Receiver operating characteristic derived from predicted probabilities
for transition to psychosis. The dashed line indicates the ROC belonging to the
BPRS-only model (AUC = 0.70), the solid line indicates the ROC derived from
the BPRS-EEG-severity combined model (AUC = 0.81)
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the specificity of prediction increases from 59–73%
when EEG is considered in addition to psychopa-
thology.
In other words, ARMS individuals that would have
been incorrectly classified as ARMS-T based on psy-
chopathology alone were reclassified when EEG find-
ings were considered additionally, thereby increasing
specificity but not sensitivity. A detailed analysis re-
vealed that subjects with a high BPRS score (>39)
could be correctly reclassified as not making a tran-
sition to psychosis later on if the EEG at baseline
investigation was normal.
As EEG is an easily available and economic test,
this result is clinically important and may have
implications for the care of individual patients.
The value of the study lies in the prospective
investigation of a sample of patients in a prodromal
state of psychosis. Limitations of the study are due to
the relatively small sample size, the lack of a cross-
validation procedure and possible selection bias of
HC.
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